MS
Meema Sukhdev Chauhan
About Meema Sukhdev Chauhan
Data last updated:
Meema Sukhdev Chauhan has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Alpha & Omega Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alpha & Omega Therapeutics Private Limited at ₹2.97 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alpha & Omega Therapeutics Private Limited U33110GJ2019PTC106995 | Director | 08 Mar 2019 | 2019 | ₹2.97 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Meema Sukhdev Chauhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meema Sukhdev Chauhan
Meema Sukhdev Chauhan has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Alpha & Omega Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alpha & Omega Therapeutics Private Limited at ₹2.97 Cr (FY 2025).
Meema Sukhdev Chauhan is associated with 1 company as Director, including Alpha & Omega Therapeutics Private Limited (₹2.97 Cr).
Meema Sukhdev Chauhan has expertise in General Business.
Meema Sukhdev Chauhan has 7 years in corporate governance.
By reported revenue, the largest current company of Meema Sukhdev Chauhan is Alpha & Omega Therapeutics Private Limited, with revenue of ₹2.97 Cr (FY 2025).
Meema Sukhdev Chauhan currently holds positions at 1 company: Alpha & Omega Therapeutics Private Limited (₹2.97 Cr).